Pancreatic Neoplasms: all 3,311 studies
Page 24 of 34. Open to participants first (911), then studies with results posted, then the rest; newest registration first within each.
- Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal CancerActive, not recruitingNCT02983578Phase 2
- Patient Reported Outcomes Registry in Patient With Cancer CachexiaCompletedNCT02983500
- Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic CancerCompletedNCT02981719Not applicable
- IORT Versus CCRT for Pancreatic CancerStatus unknownNCT02981641Not applicable
- Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic AdenocarcinomaCompletedNCT02977702
- Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic CancerStatus unknownNCT02975141Phase 1
- Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or PancreasCompletedNCT02973672Phase 1/2
- Molecularly Tailored Therapy to Standard of Care as Second-Line Therapy in Metastatic Pancreatic CancerWithdrawnNCT02967770Phase 2
- An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibActive, not recruitingNCT02955940Phase 2
- Impact of Margin-accentuation IRE in Pancreatic CancerTerminatedNCT02952859
- A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA MutationsStatus unknownNCT02950064Phase 1
- Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic CancerCompletedNCT02948309Phase 3
- Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic CancerStatus unknownNCT02945267Phase 4
- Establishment of Radiomics Database by Clinical Application of Multiparametric MRI Based on Incoherent UndersamplingStatus unknownNCT02944006
- Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic CancerStatus unknownNCT02934984
- Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT02930902Phase 1
- Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic CancerStatus unknownNCT02929797Early Phase 1
- Quality of Life After in Situ IRE in Locally Advanced Pancreatic CancerTerminatedNCT02926040
- Relationship Between Evolution of Resting Energy Expenditure and Tumoral Response to Chemotherapy in Patients Suffering From Pancreas CancerTerminatedNCT02921646Not applicable
- Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic AdenocarcinomaActive, not recruitingNCT02921022Not applicable
- Diagnostic Yield of 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic LesionsCompletedNCT02920944Not applicable
- Nordic Pancreatic Cancer Trial (NorPACT) - 1Active, not recruitingNCT02919787Phase 2/3
- Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient OutcomesActive, not recruitingNCT02917798
- A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)Active, not recruitingNCT02912949Phase 2
- Comparing Biopsy Needles for Endoscopic Ultrasound Guided Samples for Pancreatic MassesCompletedNCT02911974Not applicable
- Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic MassesCompletedNCT02910960Not applicable
- Comparison Between Olympus EZ Shot 3Plus 19G and EZ Shot 2 19G in EUS-guided FNB of Solid Pancreatic MassesCompletedNCT02909530Not applicable
- Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary CancerCompletedNCT02900950Not applicable
- Developing Prehabilitation Program in Patients With Operable Pancreatic Cancer Perioperatively and Following SurgeryStatus unknownNCT02900677Not applicable
- CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceTerminatedNCT02900248
- Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic CancerStatus unknownNCT02898649Not applicable
- Palbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsCompletedNCT02897375Phase 1
- Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic CancerStatus unknownNCT02896803Phase 2
- Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic CancerCompletedNCT02894944Phase 1
- Hepatic Resection for Metastatic Pancreatic CancerActive, not recruitingNCT02892305
- Assessment of the Cytotoxic Immune Status of Pancreatic Cancer Patients and the Severity of the Cancer Using Measurement of Natural Killer Cell ActivitiesCompletedNCT02887599Not applicable
- Durvalumab Plus "Booster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598)WithdrawnNCT02885727Phase 2
- Endoscopic Ultrasound Guided Radiofrequency Ablation (EUS-RFA) for Small Benign Pancreatic TumorsWithdrawnNCT02882503Not applicable
- Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ NeedleWithdrawnNCT02872831Not applicable
- Combined Resection vs. Separated Resection After Mobilization of Splenic Vein During Distal PancreatectomyStatus unknownNCT02871804Phase 3
- Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic CancerWithdrawnNCT02868632Phase 1
- Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer PatientsCompletedNCT02866383Phase 2
- EUS Fiducial for Pancreas SurgeryStatus unknownNCT02863783Not applicable
- A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic CancerStatus unknownNCT02863367Phase 2
- Multicenter RCT of the Clinical Effectiveness of Oncothermia With Chemotherapy in Metastatic Pancreatic Cancer PatientsStatus unknownNCT02862015Phase 2
- Onco-geriatric Database of Patients With Pancreatic CancerStatus unknownNCT02858141
- A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer PatientsStatus unknownNCT02854072Phase 3
- Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line ChemotherapyCompletedNCT02853474Phase 3
- Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine TumoursCompletedNCT02853422
- Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic CancerWithdrawnNCT02851381Not applicable
- HIPEC as Neoadjuvant Treatment for Resectable Pancreatic AdenocarcinomaWithdrawnNCT02850874Phase 2
- CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas CancerCompletedNCT02850536Phase 1
- A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic CancerCompletedNCT02841436Not applicable
- CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid TumorStatus unknownNCT02839954Phase 1/2
- Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous CachexyCompletedNCT02830620Not applicable
- Pancreas Volume and Diabetes Status Following PancreatectomyStatus unknownNCT02823678
- Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially ResectableCompletedNCT02818907Not applicable
- CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With RadiotherapyCompletedNCT02791503Not applicable
- Different Stapler Cartridge For Pancreatic Stump Texture To Prevent Pancreatic FistulaCompletedNCT02790333Not applicable
- Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying LesionsStatus unknownNCT02789371Not applicable
- Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine TumoursCompletedNCT02788565
- Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP MalignancyCompletedNCT02784353Not applicable
- Project Survival-Prospective Biomarker DiscoveryStatus unknownNCT02781012
- The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT.CompletedNCT02777463
- HYPAR Trial - Hydrocortisone vs. Pasireotide in Reducing Pancreatic Surgery ComplicationsActive, not recruitingNCT02775227Phase 4
- Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic CancerTerminatedNCT02767752Phase 2
- Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer PatientsCompletedNCT02767557Phase 2
- Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)Status unknownNCT02758587Phase 1/2
- Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS StudyStatus unknownNCT02756468
- Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph NodesStatus unknownNCT02754180Phase 2
- Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic CancerActive, not recruitingNCT02745847Not applicable
- A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic CancerWithdrawnNCT02745197Phase 2
- Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic CancerStatus unknownNCT02737228Phase 1/2
- IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic CancerStatus unknownNCT02734680Not applicable
- A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic CancerCompletedNCT02734160Phase 1
- Community-based Neuroendocrine Tumor (NET) Research StudyCompletedNCT02730104
- The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal SurgeryCompletedNCT02728921Phase 4
- Apatinib as Second-line Treatment of Advanced Pancreatic CancerStatus unknownNCT02726854Phase 2
- K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's TolerabilityCompletedNCT02720666Phase 1
- Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic CancerCompletedNCT02718859Phase 1/2
- Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic CancerStatus unknownNCT02717091Phase 2
- Phase ǀ Study on Pancreatic Cancer Treated by CyberKnifeCompletedNCT02716207Not applicable
- Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)TerminatedNCT02707328Phase 1
- A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas CancerStatus unknownNCT02707315Early Phase 1
- Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer PatientsCompletedNCT02707159Phase 2
- A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic CarcinomaStatus unknownNCT02706782Phase 1
- LOAd703 Oncolytic Virus Therapy for Pancreatic CancerCompletedNCT02705196Phase 1/2
- Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid TumorsTerminatedNCT02703571Phase 1
- International CAPS Registry: Pancreas Cancer Cases in Surveillance ProgramsCompletedNCT02703545
- Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC)CompletedNCT02702986Phase 1
- Quality Assessment in Endoscopic Retrograde Cholangiopancreatography(ERCP)CompletedNCT02698137
- Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic CancerCompletedNCT02697058Phase 2
- EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic CancerCompletedNCT02695966
- Observational Study on Quality of Life of Patients Receiving Nab-paclitaxel/Gemcitabine First Line Therapy, Including a Translational ProgramCompletedNCT02691052
- Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1TerminatedNCT02687230Phase 1
- Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN ProjectCompletedNCT02685553Phase 1
- Decitabine Combined With Gemcitabine in First-line Treatment of AdvancedPancreatic CancerStatus unknownNCT02685228Not applicable
- Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy VolunteersCompletedNCT02683824Early Phase 1
- Evaluation of Pancreatic Steatosis in Patients With Cancer of PancreasStatus unknownNCT02682394
- EUS Guided Neurolysis Celiac Block w/wo Bupivacaine in Patient Being Treated Palliatively for Pancreatic CancerTerminatedNCT02682082Not applicable